8-bromo cyclic adenosine monophosphate has been researched along with Carotid Arteriopathies, Traumatic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, YC; Kim, CS; Kim, HS; Kim, MJ; Kim, SY; Lee, IK; Lee, KM; Lee, KU; Lee, SL; Park, JY; Park, KG | 1 |
1 other study(ies) available for 8-bromo cyclic adenosine monophosphate and Carotid Arteriopathies, Traumatic
| Article | Year |
|---|---|
Cilostazol inhibits vascular smooth muscle cell growth by downregulation of the transcription factor E2F.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Animals; Carotid Artery Injuries; Catheterization; Cell Cycle Proteins; Cell Division; Cells, Cultured; Cilostazol; Colforsin; Cyclic AMP; DNA; DNA-Binding Proteins; Down-Regulation; E2F Transcription Factors; E2F1 Transcription Factor; E2F2 Transcription Factor; Humans; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Proliferating Cell Nuclear Antigen; Promoter Regions, Genetic; Rats; Rats, Sprague-Dawley; Tetrazoles; Transcription Factors; Tunica Intima | 2005 |